CIOMS Working Groups

A broad range of drug safety topics has been covered by CIOMS via working groups. Senior scientists from regulatory authorities, pharmaceutical industry and academia have joined together in order to develop consensus guidelines within areas such as international reporting of adverse drug reactions (CIOMS I reporting form), periodic drug safety update summaries and development safety update report, core clinical safety information on drugs, terminology of ADRs, standardised MedDRA queries and pharmacogenetics. There have also been joint working groups together with WHO covering drug development research and pharmacovigilance in resource-poor countries and vaccine pharmacovigilance.

Member Login



Member Login